Rosen, trusted investor counsel, encourages brainstorm cell therapeutics inc. investors to inquire about securities class action investigation – bcli

New york--(business wire)--why: rosen law firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of brainstorm cell therapeutics inc. (nasdaq: bcli) resulting from allegations that brainstorm cell may have issued materially misleading business information to the investing public. so what: if you purchased brainstorm cell securities you may be entitled to compensation without payment of any out of pocket fees or costs through.
BCLI Ratings Summary
BCLI Quant Ranking